» Articles » PMID: 19153051

BCL11A Represses HBG Transcription in K562 Cells

Overview
Specialty Hematology
Date 2009 Jan 21
PMID 19153051
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

BCL11A on chromosome 2p16 was recently shown to be a major quantitative trait locus for Hb F level and F-cell number in several populations with or without beta-hemoglobinopathy. We now show that BCL11A isoforms are expressed in K562 cells. Butyrate induction of HBG globin production in K562 is associated with reduced BCL11A. Conversely, augmented expression of BCL11A in K562 cells through transfection of BCL11A expression vector results in more than 50% reduction of HBG promoter transcription activity. This transcription repression can be abrogated by sodium butyrate. BCL11A binds to GGCCGG motif in nucleotide -56 to -51 on the HBG proximal promoter. Together, these data are consistent with BCL11A being able to bind to a core motif in the HBG proximal promoter, recruit and interact with partners to form a repression complex, leading to deacetylation of histones and down-regulation of the HBG transcription.

Citing Articles

The Impact of Polymorphisms on Endometrial Cancer Risk Among Chinese Han Females.

Cai J, Peng S, Wang H, Bao S Pharmgenomics Pers Med. 2022; 15:311-325.

PMID: 35418772 PMC: 9000540. DOI: 10.2147/PGPM.S345772.


Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects.

Junker L, Li B, Zhu X, Koti S, Cerbone R, Hendrick C Blood Cells Mol Dis. 2021; 93:102626.

PMID: 34856533 PMC: 9733664. DOI: 10.1016/j.bcmd.2021.102626.


Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.

Pace B, Perrine S, Li B, Makala L, Xu H, Takezaki M Blood Cells Mol Dis. 2021; 89:102561.

PMID: 33744514 PMC: 8409227. DOI: 10.1016/j.bcmd.2021.102561.


Transcriptome Analyses of β-Thalassemia -28(A>G) Mutation Using Isogenic Cell Models Generated by CRISPR/Cas9 and Asymmetric Single-Stranded Oligodeoxynucleotides (assODNs).

Li J, Zhou Z, Sun H, Ouyang W, Dong G, Liu T Front Genet. 2020; 11:577053.

PMID: 33193694 PMC: 7580707. DOI: 10.3389/fgene.2020.577053.


Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease.

Ernst M, Broeders M, Herrero-Hernandez P, Oussoren E, van der Ploeg A, Pijnappel W Mol Ther Methods Clin Dev. 2020; 18:532-557.

PMID: 32775490 PMC: 7393410. DOI: 10.1016/j.omtm.2020.06.022.